Jefferies Initiates Cellectis With Buy
Analysts at Jefferies initiated coverage on Cellectis SA (ADR) (NASDAQ: CLLS) with a Buy rating.
The target price for Cellectis is set to $46.
Cellectis shares closed at $32.59 on Friday.
Latest Ratings for CLLS
|Apr 2016||Ladenburg Thalmann||Initiates Coverage on||Buy|
|Jul 2015||Bank of America||Initiates Coverage on||Buy|
|May 2015||Oppenheimer||Initiates Coverage on||Outperform|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.